Date | Person | Title | Type | Name | Shares | Shares (Total) | Price | Code |
---|---|---|---|---|---|---|---|---|
2024-02-15 | Colgan Erin | Sell | Common Stock | -3627.0 | 67,462 | $0.8 | F | |
2024-02-15 | van der Horst Edward | Buy | Stock Option (Right to Buy) | 90102.0 | 90,102 | $0.0 | A | |
2024-02-15 | van der Horst Edward | Buy | Stock Option (Right to Buy) | 125000.0 | 125,000 | $0.0 | A | |
2024-02-15 | van der Horst Edward | Sell | Common Stock | -2843.0 | 56,070 | $0.8 | F | |
2024-02-15 | Celebi John | Buy | Stock Option (Right to Buy) | 165889.0 | 165,889 | $0.0 | A | |
2024-02-15 | Celebi John | Buy | Stock Option (Right to Buy) | 315000.0 | 315,000 | $0.0 | A | |
2024-02-15 | Celebi John | Sell | Common Stock | -5891.0 | 105,420 | $0.8 | F | |
2024-02-15 | Colgan Erin | Buy | Stock Option (Right to Buy) | 94128.0 | 94,128 | $0.0 | A | |
2024-02-15 | Colgan Erin | Buy | Stock Option (Right to Buy) | 125000.0 | 125,000 | $0.0 | A | |
2023-11-01 | Krebs Stephanie | Buy | Stock Option (Right to Buy) | 125000.0 | 125,000 | $0.0 | A | |
2023-09-11 | Celebi John | Buy | Common Stock | 500.0 | 111,311 | $0.9 | P | |
2023-07-31 | Peyer James | Sell | Common Stock | -1587302.0 | 3,653,120 | $1.3 | D | |
2023-07-31 | Cambrian BioPharma Inc | Sell | Common Stock | -1587302.0 | 3,653,120 | $1.3 | D | |
2023-07-10 | Holmen Bob | Buy | Common Stock | 4466.0 | 25,598 | $0.0 | A | |
2023-07-10 | Peyer James | Buy | Stock Option (Right to Buy) | 14550.0 | 14,550 | $0.0 | A | |
2023-07-10 | Peyer James | Buy | Common Stock | 4466.0 | 5,240,422 | $0.0 | A | |
2023-07-10 | Cambrian BioPharma Inc | Buy | Common Stock | 4466.0 | 5,240,422 | $0.0 | A | |
2023-07-10 | Cambrian BioPharma Inc | Buy | Stock Option (Right to Buy) | 14550.0 | 14,550 | $0.0 | A | |
2023-07-10 | Vojta Deneen | Buy | Common Stock | 4466.0 | 8,932 | $0.0 | A | |
2023-07-10 | Holmen Bob | Buy | Stock Option (Right to Buy) | 14550.0 | 14,550 | $0.0 | A |